Chemoinformaics analysis of N-formylchonemorphine
| Molecular Weight | 374.613 | nRot | 4 |
| Heavy Atom Molecular Weight | 332.277 | nRig | 21 |
| Exact Molecular Weight | 374.33 | nRing | 4 |
| Solubility: LogS | -2.973 | nHRing | 0 |
| Solubility: LogP | 5.113 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 69 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 42 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 24 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 71.0873 |
| nHD | 1 | BPOL | 45.2827 |
| QED | 0.723 |
| Synth | 4.549 |
| Natural Product Likeliness | 2.139 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.993 |
| Pgp-sub | 0.851 |
| HIA | 0.053 |
| CACO-2 | -4.774 |
| MDCK | 0.0000114 |
| BBB | 0.528 |
| PPB | 0.459442 |
| VDSS | 1.478 |
| FU | 0.439828 |
| CYP1A2-inh | 0.264 |
| CYP1A2-sub | 0.342 |
| CYP2c19-inh | 0.107 |
| CYP2c19-sub | 0.95 |
| CYP2c9-inh | 0.105 |
| CYP2c9-sub | 0.06 |
| CYP2d6-inh | 0.646 |
| CYP2d6-sub | 0.915 |
| CYP3a4-inh | 0.903 |
| CYP3a4-sub | 0.591 |
| CL | 12.522 |
| T12 | 0.094 |
| hERG | 0.767 |
| Ames | 0.21 |
| ROA | 0.676 |
| SkinSen | 0.963 |
| Carcinogencity | 0.508 |
| EI | 0.045 |
| Respiratory | 0.938 |
| NR-Aromatase | 0.002 |
| Antiviral | No |
| Prediction | 0.642447 |